Advertisement

Oral Mucosal Lesions of Systemic Diseases

  • Xin Jin
  • Xin Zeng
  • Lanyan Wu
Chapter

Abstract

Age: 29 years

Keywords

Thrombocytopenic Purpura Leukemia Acute Monocytic Leukemia Myeloid Sarcoma Lymphoma NK-/T-Cell Lymphoma Langerhans Cell Histiocytosis Amyloidosis Florid Papillomatosis Acanthosis Nigricans Maligna Focal Dermal Hypoplasia 

References

  1. 1.
    Hou M, Dai K, Peng J. Blood platelet disorders. 2nd ed. Beijing: Science and Technology Literature Press; 2013.Google Scholar
  2. 2.
    Guzeldemir E. The role of oral hygiene in a patient with idiopathic thrombocytopenic purpura. Int J Dent Hyg. 2009;7(4):289–93.PubMedCrossRefGoogle Scholar
  3. 3.
    Javed F, Utreja A, Bello CFO, et al. Oral health status in children with acute lymphoblastic leukemia. Crit Rev Oncol Hematol. 2012;83(3):303–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937–51.PubMedCrossRefGoogle Scholar
  5. 5.
    Breed CD. Diagnosis, treatment, and nursing care of patients with chronic leukemia. Semin Oncol Nurs. 2003;19(2):109–17.PubMedCrossRefGoogle Scholar
  6. 6.
    Wu J, Fantasia JE, Kaplan R. Oral manifestations of acute myelomonocytic leukemia: a case report and review of the classification of leukemias. J Periodontol. 2002;73(6):664–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Fatahzadeh M, Krakow AM. Manifestation of acute monocytic leukemia in the oral cavity: a case report. Spec Care Dentist. 2008;28(5):190–4.PubMedCrossRefGoogle Scholar
  8. 8.
    Cooper CL, Loewen R, Shore T. Gingival hyperplasia complicating acute myelomonocytic leukemia. J Can Dent Assoc. 2000;66(2):78–9.PubMedGoogle Scholar
  9. 9.
    Demirer S, Ozdemir H, Sencan M, Marakoglu I. Gingival hyperplasia as an early diagnostic oral manifestation in acute monocytic leukemia: a case report. Eur J Dent. 2007;1(2):111–4.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Begon E, Blum L, Benramdane R, et al. Oral manifestation of T-cell leukemia/lymphoma. Arch Dermatol. 2010;146(7):804–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Audouin J, Comperat E, Le TA, et al. Myeloid sarcoma: clinical and morphologic criteria useful for diagnosis. Int J Surg Pathol. 2003;11(4):271–82.PubMedCrossRefGoogle Scholar
  12. 12.
    Campidelli C, Agostinelli C, Stitson R, Pileri SA. Myeloid sarcoma: extramedullary manifestation of myeloid disorders. Am J Clin Pathol. 2009;132(3):426–37.PubMedCrossRefGoogle Scholar
  13. 13.
    Papamanthos MK, Kolokotronis AE, Skulakis HE, Fericean AM, Zorba MT, Matiakis AT. Acute myeloid leukaemia diagnosed by intra-oral myeloid sarcoma. A case report. Head Neck Pathol. 2010;4(2):132–5.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Goteri G, Ascani G, Messi M, et al. Myeloid sarcoma of the maxillary bone. J Oral Pathol Med. 2006;35(4):254–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Soares AF, Aquino AR, Carvalho CH, Nonaka CF, Almeida D, Pinto LP. Frequency of oral mucositis and microbiological analysis in children with acute lymphoblastic leukemia treated with 0.12% chlorhexidine gluconate. Braz Dent J. 2011;22(4):312–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Meng W, Zhou Y, Zhang H, et al. Nasal-type NK/T-cell lymphoma with palatal ulcer as the earliest clinical manifestation: a case report with literature review. Pathol Oncol Res. 2010;16(1):133–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program. 2009;2009:523–31.Google Scholar
  18. 18.
    Hong J, Park S, Baek HL, et al. Tumor cell nuclear diameter and CD30 expression as potential prognostic parameter in patients with extranodal NK/T-cell lymphoma, nasal type. Int J Clin Exp Pathol. 2012;5(9):939–47.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Yu WW, Hsieh PP, Chuang SS. Cutaneous EBV-positive gammadelta T-cell lymphoma vs. extranodal NK/T-cell lymphoma: a case report and literature review. J Cutan Pathol. 2012;40(3):310–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Pongpruttipan T, Sukpanichnant S, Assanasen T, et al. Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and alphabeta, gammadelta, and alphabeta/gammadelta T-cell origin: a comprehensive clinicopathologic and phenotypic study. Am J Surg Pathol. 2012;36(4):481–99.PubMedCrossRefGoogle Scholar
  21. 21.
    Kawakami K, Ito R, Tono Y, et al. Orbital inflammatory lesion as an initial manifestation of systemic nasal type NK/T-cell lymphoma. J Clin Exp Hematopathol. 2012;52(2):137–9.CrossRefGoogle Scholar
  22. 22.
    Li S, Feng X, Li T, et al. Extranodal NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center. Am J Surg Pathol. 2013;37(1):14–23.PubMedCrossRefGoogle Scholar
  23. 23.
    Pacino GA, Serrat A, Redondo LM, Verrier A. Langerhans cell histiocytosis: clinical diagnostic features and current concepts. Med Oral. 1999;4(5):607–18.PubMedGoogle Scholar
  24. 24.
    Dagenais M, Pharoah MJ, Sikorski PA. The radiographic characteristics of histiocytosis X. A study of 29 cases that involve the jaws. Oral Surg Oral Med Oral Pathol. 1992;74(2):230–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Duncan WK, Post AC, McCoy BP. Eosinophilic granuloma. Oral Surg Oral Med Oral Pathol. 1988;65(6):736–41.PubMedCrossRefGoogle Scholar
  26. 26.
    Hartman KS. Histiocytosis X: a review of 114 cases with oral involvement. Oral Surg Oral Med Oral Pathol. 1980;49(1):38–54.PubMedCrossRefGoogle Scholar
  27. 27.
    Egeler RM, D’Angio GJ. Langerhans cell histiocytosis. J Pediatr. 1995;127(1):1–11.PubMedCrossRefGoogle Scholar
  28. 28.
    Hernandez-Juyol M, Boj-Quesada JR, Gallego MS. Oral manifestations of Langerhans cell histiocytosis. Case study of a two-year-old boy. Med Oral. 2003;8(1):19–25.PubMedGoogle Scholar
  29. 29.
    Minguez I, Minguez JM, Bonet J, Penarrocha M, Sanchis JM. Oral manifestations of chronic disseminated histiocytosis. A report of 10 cases. Med Oral. 2004;9(2):152–4. 149–52.PubMedGoogle Scholar
  30. 30.
    Becelli R, Carboni A, Gianni C, Alterio A, Renzi G. A rare condition of Hand-Schuller-Christian disease. J Craniofac Surg. 2002;13(6):759–61.PubMedCrossRefGoogle Scholar
  31. 31.
    Milian MA, Bagan JV, Jimenez Y, Perez A, Scully C, Antoniades D. Langerhans’ cell histiocytosis restricted to the oral mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91(1):76–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Madrigal-Martinez-Pereda C, Guerrero-Rodriguez V, Guisado-Moya B, Meniz-Garcia C. Langerhans cell histiocytosis: literature review and descriptive analysis of oral manifestations. Med Oral Patol Oral Cir Bucal. 2009;14(5):E222–8.PubMedGoogle Scholar
  33. 33.
    Zhang K, Zeng H, Chen WQ. Clinical features and diagnosis of langerhans cell hyperplasia. Ai Zheng. 2006;25(1):88–91.PubMedGoogle Scholar
  34. 34.
    Li Y, Liu N, Xu Y, et al. Widespread purple bulla-like masses of the oral mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(5):552–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Khan MF, Falk RH. Amyloidosis. Postgrad Med J. 2001;77(913):686–93.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Steciuk A, Dompmartin A, Troussard X, et al. Cutaneous amyloidosis and possible association with systemic amyloidosis. Int J Dermatol. 2002;41(3):127–32; discussion 133–4.PubMedCrossRefGoogle Scholar
  37. 37.
    Fahrner KS, Black CC, Gosselin BJ. Localized amyloidosis of the tongue: a review. Am J Otolaryngol. 2004;25(3):186–9.PubMedCrossRefGoogle Scholar
  38. 38.
    Angiero F, Seramondi R, Magistro S, et al. Amyloid deposition in the tongue: clinical and histopathological profile. Anticancer Res. 2010;30(7):3009–14.PubMedGoogle Scholar
  39. 39.
    Danesh F, Ho LT. Dialysis-related amyloidosis: history and clinical manifestations. Semin Dial. 2001;14(2):80–5.PubMedCrossRefGoogle Scholar
  40. 40.
    Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997;337(13):898–909.PubMedCrossRefGoogle Scholar
  41. 41.
    Kyle RA, Bayrd ED. Amyloidosis: review of 236 cases. Medicine (Baltimore). 1975;54(4):271–99.PubMedCrossRefGoogle Scholar
  42. 42.
    Kerner MM, Wang MB, Angier G, Calcaterra TC, Ward PH. Amyloidosis of the head and neck. A clinicopathologic study of the UCLA experience, 1955–1991. Arch Otolaryngol Head Neck Surg. 1995;121(7):778–82.PubMedCrossRefGoogle Scholar
  43. 43.
    Rajkumar SV. Multiple myeloma: 2013 update on diagnosis, risk-stratification, and management. Am J Hematol. 2013;88(3):225–35.CrossRefGoogle Scholar
  44. 44.
    Oliveira EV, Pozetti AC, Pozetti EM, Antonio JR, Michalany NS. Primary systemic amyloidosis associated with multiple myeloma. An Bras Dermatol. 2012;87(1):119–22.PubMedCrossRefGoogle Scholar
  45. 45.
    Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78(1):21–33.PubMedCrossRefGoogle Scholar
  46. 46.
    Prokaeva T, Spencer B, Kaut M, et al. Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival. Arthritis Rheum. 2007;56(11):3858–68.PubMedCrossRefGoogle Scholar
  47. 47.
    Chang SS, Lu CL, Tsay SH, Chang FY, Lee SD. Amyloidosis-induced gastrointestinal bleeding in a patient with multiple myeloma. J Clin Gastroenterol. 2001;32(2):161–3.PubMedCrossRefGoogle Scholar
  48. 48.
    Thibault I, Vallieres I. Macroglossia due to systemic amyloidosis: is there a role for radiotherapy. Case Rep Oncol. 2011;4(2):392–9.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Bottoni U, Dianzani C, Pranteda G, et al. Florid cutaneous and mucosal papillomatosis with acanthosis nigricans revealing a primary lung cancer. J Eur Acad Dermatol Venereol. 2000;14(3):205–8.PubMedCrossRefGoogle Scholar
  50. 50.
    Yeh JS, Munn SE, Plunkett TA, Harper PG, Hopster DJ, du Vivier AW. Coexistence of acanthosis nigricans and the sign of Leser-Trelat in a patient with gastric adenocarcinoma: a case report and literature review. J Am Acad Dermatol. 2000;42(2 Pt 2):357–62.PubMedCrossRefGoogle Scholar
  51. 51.
    Tyler MT, Ficarra G, Silverman S Jr, Odom RB, Regezi JA. Malignant acanthosis nigricans with florid papillary oral lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81(4):445–9.PubMedCrossRefGoogle Scholar
  52. 52.
    Brinca A, Cardoso JC, Brites MM, Tellechea O, Figueiredo A. Florid cutaneous papillomatosis and acanthosis nigricans maligna revealing gastric adenocarcinoma. An Bras Dermatol. 2011;86(3):573–7.PubMedCrossRefGoogle Scholar
  53. 53.
    Weger W, Ginter-Hanselmayer G, Hammer HF, Hodl S. Florid cutaneous papillomatosis with acanthosis nigricans in a patient with carcinomas of the lung and prostate. J Am Acad Dermatol. 2007;57(5):907–8.PubMedCrossRefGoogle Scholar
  54. 54.
    Csete B, Moezzi M, Lengyel Z, Hodosi B, Zombai E, Battyani Z. Florid cutaneous papillomatosis leading to social exclusion. Br J Dermatol. 2005;153(3):667–9.PubMedCrossRefGoogle Scholar
  55. 55.
    Janniger EJ, Schwartz RA. Florid cutaneous papillomatosis. J Surg Oncol. 2010;102(6):709–12.PubMedCrossRefGoogle Scholar
  56. 56.
    Koyama S, Ikeda K, Sato M, et al. Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus. J Gastroenterol. 1997;32(1):71–7.PubMedCrossRefGoogle Scholar
  57. 57.
    Wang L, Jin X, Zhao X, et al. Focal dermal hypoplasia: updates. Oral Dis. 2014;20(1):17–24.PubMedCrossRefGoogle Scholar
  58. 58.
    Goltz RW, Peterson WC, Gorlin RJ, Ravits HG. Focal dermal hypoplasia. Arch Dermatol. 1962;86:708–17.PubMedCrossRefGoogle Scholar
  59. 59.
    Lasocki AL, Stark Z, Orchard D. A case of mosaic Goltz syndrome (focal dermal hypoplasia) in a male patient. Australas J Dermatol. 2011;52(1):48–51.PubMedCrossRefGoogle Scholar
  60. 60.
    Grzeschik KH, Bornholdt D, Oeffner F, et al. Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasia. Nat Genet. 2007;39(7):833–5.PubMedCrossRefGoogle Scholar
  61. 61.
    Lombardi MP, Bulk S, Celli J, et al. Mutation update for the PORCN gene. Hum Mutat. 2011;32(7):723–8.PubMedCrossRefGoogle Scholar
  62. 62.
    Quain RD, Militello G, Junkins-Hopkins J, Yan AC, Crawford GH. Erythematous atrophic macules and papules following the lines of Blaschko. Focal dermal hypoplasia (FDH), or Goltz syndrome. Arch Dermatol. 2007;143(1):109–14.PubMedCrossRefGoogle Scholar
  63. 63.
    Baxter AM, Shaw MJ, Warren K. Dental and oral lesions in two patients with focal dermal hypoplasia (Goltz syndrome). Br Dent J. 2000;189(10):550–3.PubMedGoogle Scholar
  64. 64.
    Balmer R, Cameron AC, Ades L, Aldred MJ. Enamel defects and lyonization in focal dermal hypoplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98(6):686–91.PubMedCrossRefGoogle Scholar
  65. 65.
    Seoane J, Gibson RL, Almagro M, Pintos E. Oral manifestations associated with focal dermal hypoplasia. Dermatology. 2009;219(4):368–70.PubMedCrossRefGoogle Scholar
  66. 66.
    Marcus DM, Shore JW, Albert DM. Anophthalmia in the focal dermal hypoplasia syndrome. Arch Ophthalmol. 1990;108(1):96–100.PubMedCrossRefGoogle Scholar
  67. 67.
    Prenner JL, Ciaccia S, Capone A Jr, Trese MT. Retinal detachment in focal dermal hypoplasia. Eur J Ophthalmol. 2004;14(2):166–8.PubMedCrossRefGoogle Scholar
  68. 68.
    Bhatia AM, Clericuzio CL, Musemeche CA. Congenital ventral hernia in association with focal dermal hypoplasia. Pediatr Dermatol. 1995;12(4):336–9.PubMedCrossRefGoogle Scholar
  69. 69.
    Han XY, Wu SS, Conway DH, et al. Truncus arteriosus and other lethal internal anomalies in Goltz syndrome. Am J Med Genet. 2000;90(1):45–8.PubMedCrossRefGoogle Scholar
  70. 70.
    Suskan E, Kurkcuoglu N, Uluoglu O. Focal dermal hypoplasia (Goltz syndrome) with horseshoe kidney abnormality. Pediatr Dermatol. 1990;7(4):283–6.PubMedCrossRefGoogle Scholar
  71. 71.
    Lopez-Porras RF, Arroyo C, Soto-Vega E. Focal dermal hypoplasia with uterus bicornis and renal ectopia: case report and review of the literature. Case Rep Dermatol. 2011;3(2):158–63.PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Kanemura H, Hatakeyama K, Sugita K, Aihara M. Epilepsy in a patient with focal dermal hypoplasia. Pediatr Neurol. 2011;44(2):135–8.PubMedCrossRefGoogle Scholar
  73. 73.
    Smigiel R, Jakubiak A, Lombardi MP, et al. Co-occurrence of severe Goltz-Gorlin syndrome and pentalogy of Cantrell—case report and review of the literature. Am J Med Genet A. 2011;155A(5):1102–5.PubMedCrossRefGoogle Scholar
  74. 74.
    Reddy J, Laufer MR. Congenital anomalies of the female reproductive tract in a patient with Goltz syndrome. J Pediatr Adolesc Gynecol. 2009;22(4):e71–2.PubMedCrossRefGoogle Scholar
  75. 75.
    Kimonis VE, Goldstein AM, Pastakia B, et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet. 1997;69(3):299–308.PubMedCrossRefGoogle Scholar
  76. 76.
    Bleeker-Wagemakers LM, Hamel BC, Hennekam RC, Beemer FA, Oorthuys HW. Oculocerebrocutaneous syndrome. J Med Genet. 1990;27(1):69–70.PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Prabhu NT, John R, Munshi AK. Rieger’s syndrome: a case report. Quintessence Int. 1997;28(11):749–52.PubMedGoogle Scholar
  78. 78.
    Happle R, Daniels O, Koopman RJ. MIDAS syndrome (microphthalmia, dermal aplasia, and sclerocornea): an X-linked phenotype distinct from Goltz syndrome. Am J Med Genet. 1993;47(5):710–3.PubMedCrossRefGoogle Scholar
  79. 79.
    Alster TS, Wilson F. Focal dermal hypoplasia (Goltz’s syndrome). Treatment of cutaneous lesions with the 585-nm flashlamp-pumped pulsed dye laser. Arch Dermatol. 1995;131(2):143–4.PubMedCrossRefGoogle Scholar
  80. 80.
    Liu J, Hsu PT, Vanderwielen BA, Teng JM. Treatment of recalcitrant excessive granulation tissue with photodynamic therapy in an eight-year-old patient with focal dermal hypoplasia syndrome. Pediatr Dermatol. 2012;29(3):324–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. and People's Medical Publishing House 2018

Authors and Affiliations

  • Xin Jin
    • 1
  • Xin Zeng
    • 2
  • Lanyan Wu
    • 3
  1. 1.College of StomatologyChongqing Medical University, Chongqing Key Laboratory of Oral Diseases and Biomedical SciencesChongqingChina
  2. 2.State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Department of Oral MedicineWest China Hospital of Stomatology, Sichuan UniversityChengduChina
  3. 3.Department of Oral PathologyWest China Hospital of Stomatology, Sichuan UniversityChengduChina

Personalised recommendations